source
- STAT+: Your sepsis algorithm shouldn’t require a time machineIn this edition of AI Prognosis: Quirky medical data tripping up sepsis algorithms, AI scribes for patients, and some AI biotech news.STAT · 2mo ago↗ source
- Ethyreal starts up with $101M and takes aim at a pair of immune diseasesThe startup is developing a medicine that works differently than available treatments for thyroid eye disease and could benefit people with a related condition, too.BioPharma Dive · 2mo ago↗ source
- Sanofi stops immune drug trial in latest research setbackThe failure adds to a series of mixed or negative readouts and leaves in doubt the future of a therapy Sanofi has viewed as a potential blockbuster.BioPharma Dive · 2mo ago↗ source